186 related articles for article (PubMed ID: 26457240)
1. MicroRNA-Specificity Protein (Sp) Transcription Factor Interactions and Significance in Carcinogenesis.
Safe S
Curr Pharmacol Rep; 2015 Apr; 1(2):73-78. PubMed ID: 26457240
[TBL] [Abstract][Full Text] [Related]
2. Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs.
Gandhy SU; Kim K; Larsen L; Rosengren RJ; Safe S
BMC Cancer; 2012 Nov; 12():564. PubMed ID: 23194063
[TBL] [Abstract][Full Text] [Related]
3. Induction of the transcriptional repressor ZBTB4 in prostate cancer cells by drug-induced targeting of microRNA-17-92/106b-25 clusters.
Kim K; Chadalapaka G; Pathi SS; Jin UH; Lee JS; Park YY; Cho SG; Chintharlapalli S; Safe S
Mol Cancer Ther; 2012 Sep; 11(9):1852-62. PubMed ID: 22752225
[TBL] [Abstract][Full Text] [Related]
4. Specificity protein (Sp) transcription factors Sp1, Sp3 and Sp4 are non-oncogene addiction genes in cancer cells.
Hedrick E; Cheng Y; Jin UH; Kim K; Safe S
Oncotarget; 2016 Apr; 7(16):22245-56. PubMed ID: 26967243
[TBL] [Abstract][Full Text] [Related]
5. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells.
Mertens-Talcott SU; Chintharlapalli S; Li X; Safe S
Cancer Res; 2007 Nov; 67(22):11001-11. PubMed ID: 18006846
[TBL] [Abstract][Full Text] [Related]
6. Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer.
Kim K; Chadalapaka G; Lee SO; Yamada D; Sastre-Garau X; Defossez PA; Park YY; Lee JS; Safe S
Oncogene; 2012 Feb; 31(8):1034-44. PubMed ID: 21765466
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of action of phenethylisothiocyanate and other reactive oxygen species-inducing anticancer agents.
Jutooru I; Guthrie AS; Chadalapaka G; Pathi S; Kim K; Burghardt R; Jin UH; Safe S
Mol Cell Biol; 2014 Jul; 34(13):2382-95. PubMed ID: 24732804
[TBL] [Abstract][Full Text] [Related]
8. Specificity Proteins (Sp) and Cancer.
Safe S
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982239
[TBL] [Abstract][Full Text] [Related]
9. Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors.
Chintharlapalli S; Papineni S; Lei P; Pathi S; Safe S
BMC Cancer; 2011 Aug; 11():371. PubMed ID: 21864401
[TBL] [Abstract][Full Text] [Related]
10. REACTIVE OXYGEN SPECIES AND COLORECTAL CANCER.
Sreevalsan S; Safe S
Curr Colorectal Cancer Rep; 2013 Dec; 9(4):350-357. PubMed ID: 25584043
[TBL] [Abstract][Full Text] [Related]
11. Celastrol decreases specificity proteins (Sp) and fibroblast growth factor receptor-3 (FGFR3) in bladder cancer cells.
Chadalapaka G; Jutooru I; Safe S
Carcinogenesis; 2012 Apr; 33(4):886-94. PubMed ID: 22334592
[TBL] [Abstract][Full Text] [Related]
12. Combination of quercetin and hyperoside has anticancer effects on renal cancer cells through inhibition of oncogenic microRNA-27a.
Li W; Liu M; Xu YF; Feng Y; Che JP; Wang GC; Zheng JH
Oncol Rep; 2014 Jan; 31(1):117-24. PubMed ID: 24173369
[TBL] [Abstract][Full Text] [Related]
13. GT-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen species-microRNA-27a: ZBTB10-specificity protein pathway.
Pathi SS; Jutooru I; Chadalapaka G; Sreevalsan S; Anand S; Thatcher GR; Safe S
Mol Cancer Res; 2011 Feb; 9(2):195-202. PubMed ID: 21156786
[TBL] [Abstract][Full Text] [Related]
14. Piperlongumine Induces Reactive Oxygen Species (ROS)-Dependent Downregulation of Specificity Protein Transcription Factors.
Karki K; Hedrick E; Kasiappan R; Jin UH; Safe S
Cancer Prev Res (Phila); 2017 Aug; 10(8):467-477. PubMed ID: 28673967
[TBL] [Abstract][Full Text] [Related]
15. Betulinic acid decreases ER-negative breast cancer cell growth in vitro and in vivo: role of Sp transcription factors and microRNA-27a:ZBTB10.
Mertens-Talcott SU; Noratto GD; Li X; Angel-Morales G; Bertoldi MC; Safe S
Mol Carcinog; 2013 Aug; 52(8):591-602. PubMed ID: 22407812
[TBL] [Abstract][Full Text] [Related]
16. The drug resistance suppression induced by curcuminoids in colon cancer SW-480 cells is mediated by reactive oxygen species-induced disruption of the microRNA-27a-ZBTB10-Sp axis.
Noratto GD; Jutooru I; Safe S; Angel-Morales G; Mertens-Talcott SU
Mol Nutr Food Res; 2013 Sep; 57(9):1638-48. PubMed ID: 23471840
[TBL] [Abstract][Full Text] [Related]
17. Unifying mechanisms of action of the anticancer activities of triterpenoids and synthetic analogs.
Safe SH; Prather PL; Brents LK; Chadalapaka G; Jutooru I
Anticancer Agents Med Chem; 2012 Dec; 12(10):1211-20. PubMed ID: 22583404
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol and quercetin in combination have anticancer activity in colon cancer cells and repress oncogenic microRNA-27a.
Del Follo-Martinez A; Banerjee N; Li X; Safe S; Mertens-Talcott S
Nutr Cancer; 2013; 65(3):494-504. PubMed ID: 23530649
[TBL] [Abstract][Full Text] [Related]
19. The transcriptional repressor ZBTB4 regulates EZH2 through a MicroRNA-ZBTB4-specificity protein signaling axis.
Yang WS; Chadalapaka G; Cho SG; Lee SO; Jin UH; Jutooru I; Choi K; Leung YK; Ho SM; Safe S; Kim K
Neoplasia; 2014 Dec; 16(12):1059-69. PubMed ID: 25499219
[TBL] [Abstract][Full Text] [Related]
20. Specificity Protein Transcription Factors and Cancer: Opportunities for Drug Development.
Safe S; Abbruzzese J; Abdelrahim M; Hedrick E
Cancer Prev Res (Phila); 2018 Jul; 11(7):371-382. PubMed ID: 29545399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]